It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The local immune mechanisms responsible for the establishment and development of Echinococcus granulosus sensu stricto infection in the liver, have been little explored. We developed a suitable experimental model that mimics naturally infected livers using portal injection of protoscoleces. Opposite to Echinococcus multilocularis infection which is dose-dependent, fully mature hydatid cysts can be established in the liver whatever the injection dose; although most of the infection sites were seen at the establishment phase as inflammatory granulomas associated with fibrosis, they never matured into cysts. At the establishment phase, a strong immune response was composed of T and B cells, with T1-type, T2-type cells and cytokines and IL-10-secreting CD8+ T cells in the liver. At the established phase, results suggested a local production of antibodies by B cells, and an involvement of NK and NKT cells. Infection outcome and local immune response in the liver, were different in the mouse models of Echinococcus granulosus sensu stricto and Echinococcus multilocularis respectively; however, only early specificities at the microenvironment level might explain the major differences found between the lesions induced by the two species. Our quantitative experimental model appears fully appropriate to further study this microenvironment and its relationship with each cestode species.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asia, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China; Department of Hepatic Hydatid and Hepatobiliary Surgery, Digestive and Vascular Surgery Centre, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China; Xinjiang Key Laboratory of Echinococcosis, and WHO-Collaborating Center on Prevention and Care Management of Echinococcosis, Clinical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
2 Xinjiang Key Laboratory of Echinococcosis, and WHO-Collaborating Center on Prevention and Care Management of Echinococcosis, Clinical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China; Basic Medical College, Xinjiang Medical University, Urumqi, Xinjiang, China
3 Chronic Disease Laboratory, Institutes for Life Sciences and School of Medicine, South China University of Technology, Guangzhou, China
4 Xinjiang Key Laboratory of Echinococcosis, and WHO-Collaborating Center on Prevention and Care Management of Echinococcosis, Clinical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
5 State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asia, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China; Xinjiang Key Laboratory of Echinococcosis, and WHO-Collaborating Center on Prevention and Care Management of Echinococcosis, Clinical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
6 State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asia, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China; Department of Hepatic Hydatid and Hepatobiliary Surgery, Digestive and Vascular Surgery Centre, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
7 French National Reference Center for Echinococcosis, Department of Parasitology, University Hospital, Besançon, France; University Bourgogne Franche-Comté (EA 3181), Besançon, France